数据链接：
官方服务：
资源简介：
Clinical parameters of EAE progression.
应用场景：
创建时间：
2017-06-27
相关数据集
Clinical and histological outcome of rMOG EAE in ngr1 −/− .
Data represent mean ± SEM. *p≤0.05. Wild Type (WT) and Nogo Receptor 1 deficient (ngr1−/−) values are shown for the peak (18 days post-immunization, dpi) and the chronic (45dpi) stage of recombinant M
NIAID Data Ecosystem80
Data_Sheet_1_The Selective HDAC6 Inhibitor ACY-738 Impacts Memory and Disease Regulation in an Animal Model of Multiple Sclerosis.docx
Multiple sclerosis (MS) is a complex disease characterized by autoimmune demyelination and progressive neurodegeneration. Pathogenetic mechanisms of the disease remain largely unknown. Changes in syna
NIAID Data Ecosystem40
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis
A combination of molecular modeling and structure–activity relationship studies has been used to fine-tune CB2 selectivity in the chromenopyrazole ring, a versatile CB1/CB2 cannabinoid scaffold. Thus,
NIAID Data Ecosystem30
Fig 1 (panels F, G, H, I, J)
Dhh, Icam1, Vcam1, Cldn5, Zo1 mRNA expression level in enriched neurovascular fractions from EAE MOG induced C57BL/6 mice vs C57BL/6 mice treated with placebo.
NIAID Data Ecosystem50
Novel Model of Multiple Sclerosis Induced by EBV-like Virus Generates a Unique B Cell Population. Novel Model of Multiple Sclerosis Induced by EBV-like Virus Generates a Unique B Cell Population
Objective: Multiple sclerosis (MS) is a chronic, autoimmune disease of the central nervous system. Prior infection with Epstein-Barr virus (EBV), a gammaherpesvirus, is deemed a necessary yet insuffic
NIAID Data Ecosystem40
